No Data
No Data
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study
Express News | Hyperfine Enrolls Initial Patients In NEURO PMR Study
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
With A 27% Price Drop For Hyperfine, Inc. (NASDAQ:HYPR) You'll Still Get What You Pay For
Lake Street Initiates Hyperfine(HYPR.US) With Buy Rating, Announces Target Price $1.5
Hyperfine's Growth Potential and Strategic Refocus Drive Buy Rating